Home / Brands / First Royal Care Co. LLC,

First Royal Care Co. LLC, Recalls

140 recalls on record · November 13, 2019 to November 3, 2021 · Drugs

Recalls by year

Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls SODIUM SELINITE 200MCG/ML FOR INJ, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls PROGESTERONE 100MG/ML MDV OIL INJECTION, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls MIT/B12 25/50/50MG/ML 1MG/ML MDV, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls MIC/B12A/B6 15/50/100 5MG/50MG/ML MDV, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls MIC/B12A 25/50/50MG/ML 1MG/ML MDV, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls MIC 25/50/50MG/ML MDV, Rx only,Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls METHYLCOBALAMIN 5000MCG/ML MDV INJ, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls METHYLCOBALAMIN 12.5MG/ML MDV INJ SOLN, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls METHYLCOBALAMIN 1000MCG/ML MDV INJ, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls METHYLCOBALAMIN 10,000MCG/ML MDV INJ, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls FOLIC ACID 10MG/ML MDV INJ, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls CALCIUM GLUCONATE 10% INJ (PF), Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls BENZALKONIUM CHLORIDE 0.013% SOLUTION, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls ACETYLCYSTEINE 2% OPTH SOLN, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls ACETYLCYSTEINE 10% OPTH SOLN, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls VIT B COMPLEX INJ SOLN (HP), Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls VIT B COMPLEX INJ SOLN (HP), Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls TESTOSTERONE ULTRA 250MG/ML MDV IN SESAME OIL, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls TEST CYP/PROP/DECA-NAN 125MG/ML (80/10/10) IN SESAME OIL, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls TEST CYP/PROP/DECA-NAN 125MG/ML (80/10/10) IN SESAME OIL, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls TEST CYP/PROP 160/40MG/ML MDV IN ETHYL OLEATE, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls TEST CYP 50MG/ML IN ETHYL OLEATE OIL, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls TEST CYP 25MG/ML IN ETHYL OLEATE MDV, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls TEST CYP 200MG/ML MDV ETHYL OLEATE, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls TEST CYP 200MG/ML IN SESAME OIL MDV, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls TEST CYP 100MG/ML IN ETHYL OLEATE OIL, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls PYRIDOXINE HCL (B6) 100MG/ML MDV, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls LEVOCARNITINE 100MG/ML MDV SOLN, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls HYDROXYPROG CAPROATE 250MG/ML OIL INJ, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

November 3, 2021DrugsFDA

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalls GLUTATHIONE 200MG/ML MDV, Rx only, Red Mountain Compounding Rx

Hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns